Respira Therapeutics Introduces Breakthrough Solutions For Respiratory Diseases

Published: Jun 09, 2011

SANTA FE, N.M. & AUSTIN, Texas--(BUSINESS WIRE)--Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients’ lives, introduces the company’s Dry Powder Inhaler (DPI) as a breakthrough solution for the pharmaceutical industry. Based on proprietary drug engine technology (DET), Respira Therapeutics’ DPI significantly improves therapeutic performance and enables addressing the unmet medical needs of patients with severe respiratory diseases.

Back to news